Gareth Morgan, M.D., FRCP, FRCPath, Ph.D.
Gareth Morgan, M.D., FRCP, FRCPath, Ph.D.Director, Myeloma Institute
Dr. Morgan is an internationally recognized clinician scientist who works in the field of molecular genetics of blood cell cancers, in particular, multiple myeloma. Profile
Faith Davies, M.D., MRCP, MRCPath, FRCPath
Faith Davies, M.D., MRCP, MRCPath, FRCPathDeputy Director, Myeloma Institute; Director of Developmental Therapeutics; Director, Phase I Clinical Trials Program
Dr. Davies is recognized internationally for her focus on innovative targeted molecular therapies and her expertise in the treatment of relapsed and refractory disease. Profile
Frits van Rhee, M.D., Ph.D., MRCP, FRCPath
Frits van Rhee, M.D., Ph.D., MRCP, FRCPathDirector of Developmental and Translational Medicine
Dr. van Rhee’s research focuses on immunotherapy for myeloma. Dr. van Rhee is also a leading expert in Castleman Disease.Profile
Maurizio Zangari, M.D.
Maurizio Zangari, M.D.Director of Myeloma Bone Disease Research
He is an internationally recognized expert in multiple myeloma with an extensive bibliography of peer-reviewed articles and invited presentations. Profile
Carolina Schinke, M.D.
Carolina Schinke, M.D.Assistant Professor
Dr. Schinke completed advanced training in Hematology/Oncology at Montefiore Medical Center in New York City. Profile
Sharmilan Thanendrarajan, M.D.
Sharmilan Thanendrarajan, M.D.Assistant Professor of Medicine
Dr. Thanendrarajan earned his medical degrees from Ruhr University Bochum in Germany.Profile